The use of modern biotechnology may allow for the production of more effective and economically produced pharmaceuticals since they can be made in larger quantities from existing genetic sources. A genetic diagnostic is a process of identifying and testing for suspected congenital abnormalities before administering genetic testing-based treatment.
The following section describes how biotechnology may benefit your pharmacy:
Biotechnology plays an important role when it comes to pharmaceuticals
1. Diagnostic Genetics and Gene Therapy
Genetic diagnosis via genetic testing is used to describe screening for suspected congenital abnormalities before administering treatment. It is advised that family members get genetic testing if they have a disease-causing gene passed down through the generations.
Treatment regimens are developed based on genetic tests that determine the kind of cancer being treated. If inherited gene mutations cause the condition, other female relatives should be tested for the disease and undergo routine breast cancer screening. Further, fetal genetic testing can determine whether or not a disease-causing gene is present in a family with a particularly severe illness.
During genetic testing, the DNA molecule is studied in its natural state. A scientist analyses a patient’s DNA sample to see whether any sequences have been changed. Gene testing may be divided into two broad types.
A researcher creates small DNA fragments with corresponding sequences to the changed arrangements in the first kind of experiment described above. These probes will look for their related lines inside the base pairs of a person’s genetic code. The patient’s genome may include the mutation in which case the probe will bind to it and label it.
The Seabourn test compares the sequence of DNA bases present in the patient’s gene to the line of DNA bases present in a standard version of the gene.
2. Psychoactive Substances Are Distributed Around the World
A pharmacist is an essential player in the distribution of pharmaceuticals. Most biotechnology drugs are proteins, and ingesting them would cause them to be rendered ineffective. Depending on the situation, these drugs may be delivered intravenously or in other non-traditional methods.
In addition to this, many drugs need certain storage conditions to be effective. Because the Pharmacist is acquainted with all of these requirements, they should have no trouble dealing with these products.
3. Clinical Surveillance
Clinical surveillance is the term that refers to the monitoring of patients in a clinical setting. A pharmacist is knowledgeable in prescription dosage, drug kinetics, and therapeutic monitoring, among other things. This section discusses a potential pharmacist role in the field of clinical observation for ERP software for the pharmaceutical industry.
4. Pharmacogenomics
Currently, millions of people with high cholesterol use statins, a kind of drug that is quite similar. The medicine, an inhibitor of 3-hydroxy-3-methylglutaryl-CoA reductase, which is the rate-limiting enzyme in cholesterol production, lowers cholesterol levels in the blood by stimulating the growth of low-density lipoprotein (LDL) receptors in the liver, according to the manufacturer.
The increased numbers of LDL-receptors stimulate the catabolism of plasma LDL, which eliminates cholesterol from the bloodstream and is a crucial contributor to the development of atherosclerotic plaque.
On the other hand, many of these folks may have a radically different response to these treatments. It has a significant influence on some people’s cholesterol levels, while it may have a negligible impact on others and may have no effect on others.
What is the cause of this discrepancy? Pharmacogenomics, a combination of the sciences of pharmacology and genomics that refers to the study of the interaction between pharmaceuticals and genetics, may be able to explain and simplify this problem since everyone has a different genetic background than the other.
5. Research
Because most biotechnology products have a short half-life in the bloodstream, they are often conjugated with other substances such as Liposomes, proteins, and other molecules to provide new dosage forms for administration.
The half-life and bioavailability of the product are increased due to this. Because the pharmacist is an expert in the development of medicine formulations, they may be able to contribute significantly to its development.
As a clinical researcher, the pharmacist is in charge of determining the dosing schedule and any adverse effects that may occur. As well as incompatibilities between biotechnology items and other parenteral drugs, he may provide recommendations.
Conclusion
Pharmaceutical research in biopharmaceutics is a new sector that requires the expertise of specialized experts, primarily pharmacists, to provide patients with the most effective and safe therapy possible.
Planning on becoming a pharmacist? Then this article is right for you.
